Cargando…

Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients

Recurrence is a major problem for prostate cancer patients, thus, identifying prognosis-related markers to evaluate clinical outcomes is essential. Here, we established a fifteen-miRNA-based recurrence-free survival (RFS) predicting signature based on the miRNA expression profile extracted from The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Zichen, Huang, Xinbo, Chen, Yiding, Meng, Jialin, Feng, Xingliang, Zhang, Meng, Zhang, Li, Zhou, Jun, Liang, Chaozhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738977/ https://www.ncbi.nlm.nih.gov/pubmed/33390797 http://dx.doi.org/10.7150/ijms.49412

Ejemplares similares

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

Integrated Analysis Revealed Prognostic Factors for Prostate Cancer Patients
por: Che, Hong, et al.
Publicado: (2019)

Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrinogen in Predicting Recurrence-Free Survival Time of Renal Cancer
por: Bian, Zichen, et al.
Publicado: (2020)

In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023)

Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer
por: Chen, Jing, et al.
Publicado: (2022)

Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation
por: Feng, Xingliang, et al.
Publicado: (2020)

Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
por: Meng, Tongyu, et al.
Publicado: (2022)

Establishment of an age‐ and tumor microenvironment‐related gene signature for survival prediction in prostate cancer
por: Chen, Lei, et al.
Publicado: (2022)

Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool
por: Luedemann, Christoph, et al.
Publicado: (2022)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
por: Lin, Yan, et al.
Publicado: (2017)

A miRNA signature assessing ovarian cancer prognosis
por: Bagnoli, Marina, et al.
Publicado: (2016)

Seven protective miRNA signatures for prognosis of cervical cancer
por: Liu, Bei, et al.
Publicado: (2016)

Development and external validation of a nomogram for predicting renal function based on preoperative data from in-hospital patients with simple renal cysts
por: Chen, Yiding, et al.
Publicado: (2022)

Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair‐based signature
por: Lu, Xiaofan, et al.
Publicado: (2021)

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer
por: Arrighetti, Noemi, et al.
Publicado: (2021)

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
por: Meng, Jialin, et al.
Publicado: (2022)

A Novel Defined PANoptosis-Related miRNA Signature for Predicting the Prognosis and Immune Characteristics in Clear Cell Renal Cell Carcinoma: A miRNA Signature for the Prognosis of ccRCC
por: Wang, Yanmei, et al.
Publicado: (2023)

Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma
por: Zhou, Jinhui, et al.
Publicado: (2022)

The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2019)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
por: Barbano, Raffaela, et al.
Publicado: (2014)

Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer
por: Lu, Jing, et al.
Publicado: (2021)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer
por: Qi, Wenqian, et al.
Publicado: (2021)

Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
por: Meng, Jialin, et al.
Publicado: (2020)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

A 3‐miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post‐operative radiotherapy
por: Xu, Xinbo, et al.
Publicado: (2019)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
por: Gonzalez dos Anjos, Laura, et al.
Publicado: (2018)

Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
por: Yin, Xiao-Hong, et al.
Publicado: (2019)

Identification of a four-miRNA signature predicts the prognosis of papillary thyroid cancer
por: Yang, Fan, et al.
Publicado: (2023)

Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma
por: Liu, Yu, et al.
Publicado: (2020)

Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
por: Zhang, Meng, et al.
Publicado: (2021)

A miRNA expression signature that separates between normal and malignant prostate tissues
por: Carlsson, Jessica, et al.
Publicado: (2011)

Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
por: Bian, Xiaojie, et al.
Publicado: (2015)

Genetic Polymorphisms of IFNG, IFNGR1, and Androgen Receptor and Chronic Prostatitis/Chronic Pelvic Pain Syndrome in a Chinese Han Population
por: Chen, Lei, et al.
Publicado: (2021)

Does miR-618 rs2682818 variant affect cancer susceptibility? Evidence from 10 case–control studies
por: Feng, Xingliang, et al.
Publicado: (2019)

Adipogenic miRNA and meta-signature miRNAs involved in human adipocyte differentiation and obesity
por: Shi, Chunmei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0j7bij8n4u7fhan87cv1q8dnlj